(OXY) Occidental Petroleum - Ratings and Ratios
Oil, Gasoline, Chemicals, Plastics, Pipeline
OXY EPS (Earnings per Share)
OXY Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 28.5% |
| Value at Risk 5%th | 45.3% |
| Relative Tail Risk | -3.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.37 |
| Alpha | -26.82 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.423 |
| Beta | 0.966 |
| Beta Downside | 1.400 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.61% |
| Mean DD | 22.22% |
| Median DD | 19.07% |
Description: OXY Occidental Petroleum September 29, 2025
Occidental Petroleum Corp. (NYSE: OXY) operates through three core segments-Oil & Gas, Chemicals, and Midstream & Marketing-focused on acquiring, exploring, and developing oil and gas assets in the U.S. and abroad, while also producing basic chemicals (e.g., chlorine, PVC) and providing gathering, processing, and transportation services for hydrocarbons and CO₂.
Key operational metrics from the most recent quarterly report (Q2 2024) show crude-oil-equivalent production of roughly 1.2 million boe/d, a 7 % YoY increase driven largely by the Permian Basin expansion, and adjusted EBITDA of $2.1 bn, reflecting higher oil prices (WTI ≈ $85 / bbl) and modestly improving chemical margins. The company’s net debt stands at about $30 bn, yielding a debt-to-EBITDA ratio near 4.5×, which remains a material risk if commodity prices revert to lower levels. Sector-wide drivers include OPEC+ output policy, U.S. shale cost curves, and the growing demand for low-carbon solutions-areas where Occidental’s CO₂-EOR projects could provide a strategic edge.
For a deeper, data-driven dive into Occidental’s valuation assumptions and scenario analysis, you may find ValueRay’s platform a useful next step.
OXY Stock Overview
| Market Cap in USD | 41,399m |
| Sub-Industry | Integrated Oil & Gas |
| IPO / Inception | 1981-12-31 |
| Return 12m vs S&P 500 | -24.9% |
| Analyst Rating | 3.33 of 5 |
OXY Dividends
| Dividend Yield | 2.20% |
| Yield on Cost 5y | 7.81% |
| Yield CAGR 5y | 1.78% |
| Payout Consistency | 91.6% |
| Payout Ratio | 35.6% |
OXY Growth Ratios
| CAGR 3y | -14.47% |
| CAGR/Max DD Calmar Ratio | -0.30 |
| CAGR/Mean DD Pain Ratio | -0.65 |
| Current Volume | 8617.3k |
| Average Volume | 9536.6k |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (2.07b TTM) > 0 and > 6% of Revenue (6% = 1.61b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -2.27% (prev 0.05%; Δ -2.32pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 11.25b > Net Income 2.07b (YES >=105%, WARN >=100%) |
| Net Debt (20.72b) to EBITDA (12.15b) ratio: 1.71 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.94 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.01b) change vs 12m ago 3.56% (target <= -2.0% for YES) |
| Gross Margin 33.57% (prev 35.27%; Δ -1.70pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 31.63% (prev 32.07%; Δ -0.43pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.58 (EBITDA TTM 12.15b / Interest Expense TTM 1.19b) >= 6 (WARN >= 3) |
Altman Z'' 1.67
| (A) -0.01 = (Total Current Assets 8.81b - Total Current Liabilities 9.42b) / Total Assets 83.47b |
| (B) 0.27 = Retained Earnings (Balance) 22.20b / Total Assets 83.47b |
| (C) 0.05 = EBIT TTM 4.26b / Avg Total Assets 84.64b |
| (D) 0.48 = Book Value of Equity 22.64b / Total Liabilities 46.71b |
| Total Rating: 1.67 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.56
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 6.12% = 3.06 |
| 3. FCF Margin 14.19% = 3.55 |
| 4. Debt/Equity 0.63 = 2.31 |
| 5. Debt/Ebitda 1.71 = 0.57 |
| 6. ROIC - WACC (= -0.40)% = -0.50 |
| 7. RoE 5.87% = 0.49 |
| 8. Rev. Trend -57.24% = -4.29 |
| 9. EPS Trend -62.45% = -3.12 |
What is the price of OXY shares?
Over the past week, the price has changed by +3.51%, over one month by +1.14%, over three months by -3.98% and over the past year by -13.86%.
Is Occidental Petroleum a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of OXY is around 36.38 USD . This means that OXY is currently overvalued and has a potential downside of -14.92%.
Is OXY a buy, sell or hold?
- Strong Buy: 4
- Buy: 4
- Hold: 17
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the OXY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.5 | 18.1% |
| Analysts Target Price | 50.5 | 18.1% |
| ValueRay Target Price | 39.8 | -6.9% |
OXY Fundamental Data Overview November 15, 2025
P/E Trailing = 30.8971
P/E Forward = 17.5747
P/S = 1.5563
P/B = 1.4767
P/EG = 2.1366
Beta = 0.392
Revenue TTM = 26.77b USD
EBIT TTM = 4.26b USD
EBITDA TTM = 12.15b USD
Long Term Debt = 20.21b USD (from longTermDebt, last quarter)
Short Term Debt = 2.03b USD (from shortTermDebt, last quarter)
Debt = 22.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.72b USD (from netDebt column, last quarter)
Enterprise Value = 62.12b USD (41.40b + Debt 22.88b - CCE 2.16b)
Interest Coverage Ratio = 3.58 (Ebit TTM 4.26b / Interest Expense TTM 1.19b)
FCF Yield = 6.12% (FCF TTM 3.80b / Enterprise Value 62.12b)
FCF Margin = 14.19% (FCF TTM 3.80b / Revenue TTM 26.77b)
Net Margin = 7.72% (Net Income TTM 2.07b / Revenue TTM 26.77b)
Gross Margin = 33.57% ((Revenue TTM 26.77b - Cost of Revenue TTM 17.79b) / Revenue TTM)
Gross Margin QoQ = 32.62% (prev 30.19%)
Tobins Q-Ratio = 0.74 (Enterprise Value 62.12b / Total Assets 83.47b)
Interest Expense / Debt = 1.18% (Interest Expense 270.0m / Debt 22.88b)
Taxrate = 27.79% (324.0m / 1.17b)
NOPAT = 3.07b (EBIT 4.26b * (1 - 27.79%))
Current Ratio = 0.94 (Total Current Assets 8.81b / Total Current Liabilities 9.42b)
Debt / Equity = 0.63 (Debt 22.88b / totalStockholderEquity, last quarter 36.26b)
Debt / EBITDA = 1.71 (Net Debt 20.72b / EBITDA 12.15b)
Debt / FCF = 5.45 (Net Debt 20.72b / FCF TTM 3.80b)
Total Stockholder Equity = 35.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.48% (Net Income 2.07b / Total Assets 83.47b)
RoE = 5.87% (Net Income TTM 2.07b / Total Stockholder Equity 35.21b)
RoCE = 7.68% (EBIT 4.26b / Capital Employed (Equity 35.21b + L.T.Debt 20.21b))
RoIC = 6.07% (NOPAT 3.07b / Invested Capital 50.62b)
WACC = 6.47% (E(41.40b)/V(64.27b) * Re(9.58%) + D(22.88b)/V(64.27b) * Rd(1.18%) * (1-Tc(0.28)))
Discount Rate = 9.58% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 3.12%
[DCF Debug] Terminal Value 68.18% ; FCFE base≈4.14b ; Y1≈3.26b ; Y5≈2.14b
Fair Price DCF = 31.62 (DCF Value 31.16b / Shares Outstanding 985.2m; 5y FCF grow -25.35% → 3.0% )
EPS Correlation: -62.45 | EPS CAGR: -28.50% | SUE: 1.30 | # QB: 1
Revenue Correlation: -57.24 | Revenue CAGR: -7.55% | SUE: -0.55 | # QB: 0
Additional Sources for OXY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle